Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 4 institutions in 4 countries.
Heitor Gobbi SebinelliDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.ORCID 0000-0002-4961-560X
Luiz Henrique Silva AndrilliDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.
Bruno Zoccaratto FavarinDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.
Marcos Aantonio Eufrasio CruzDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.
Maytê BoleanDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.
Michele FioreUniversity Lyon, Université. Claude Bernard Lyon 1, CNRS UMR 5246, ICBMS, F-69622 Lyon, France.ORCID 0000-0001-8176-9249
Carolina ChieffoUniversity Lyon, Université. Claude Bernard Lyon 1, CNRS UMR 5246, ICBMS, F-69622 Lyon, France.
David MagneUniversity Lyon, Université. Claude Bernard Lyon 1, CNRS UMR 5246, ICBMS, F-69622 Lyon, France.ORCID 0000-0002-6511-9390
Andrea MagriniDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Ana Paula RamosDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.ORCID 0000-0001-6200-8989
José Luis MillánSanford Burnham Prebys, La Jolla, CA 92037, USA.
Saida MebarekUniversity Lyon, Université. Claude Bernard Lyon 1, CNRS UMR 5246, ICBMS, F-69622 Lyon, France.
Rene BuchetUniversity Lyon, Université. Claude Bernard Lyon 1, CNRS UMR 5246, ICBMS, F-69622 Lyon, France.ORCID 0000-0002-7966-3856
Massimo BottiniDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.ORCID 0000-0001-9237-8972
Pietro CiancagliniDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo (FFCLRP-USP), Ribeirão Preto, São Paulo 14040-900, Brazil.ORCID 0000-0002-2785-1345
Universidade de Ribeirão Preto · BRUniversité Claude Bernard Lyon 1 · FRUniversity of Rome Tor Vergata · ITSanford Burnham Prebys Medical Discovery Institute · US
Funding
Brazil-France USP-COFECUB Uc Sv 184/20Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001, 1738449, 88887.320304/2019-00 and 88887.368020/2019-00National Council for Scientific and Technological Development 304021/2017-2; 305426/2021-4PVE-Print CAPES-USP 2020-88887.569449/2020-00São Paulo Research Foundation 2017/20846-2; 2019/08568-2; 2019/25054-2; 2021/13140-1 and 2022/05026-7University of Rome Tor Vergata Bando Visiting Professor, Prot. n. 0058868 12/12/2021
6 · The paper itself
Abstract
Matrix vesicles (MVs) contain the whole machinery necessary to initiate apatite formation in their lumen. We suspected that, in addition to tissue-nonspecific alkaline phosphatase (TNAP), Na,K,-ATPase (NKA) could be involved in supplying phopshate (P
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Shedding Light on the Role of Na,K-ATPase as a Phosphatase during Matrix-Vesicle-Mediated Mineralization. · full record | OpenQuestion